1 juli 2026 Sweden
In an interview with BioStock, Diamyd Medical’s Head of Manufacturing Site, Sofia Mayans, discusses the search for a strategic partner for the company’s newly GMP-certified manufacturing facility in Umeå. – It is about finding our niche. We are trying to read the market, understand what is needed, and talk to potential partners to see whether we could fit into their operations, says Sofia Mayans. Read the article here
|
25 juni 2026 Sweden
”Times are really tough currently. Whilst I do not wish anybody to go through what we currently are experiencing, I feel the need to step in as the CEO. At least for a short while. Yes, I am an old man. But with some experience.” So writes Anders Essen-Möller in his CEO statement in Diamyd Medical’s Q3 report. It is an unusually candid letter from a founder stepping back in at the helm of a company he built, at a moment when it stands at a crossroads. Read the article here
|
5 juni 2026 Sweden
Diamyd Medical reports that it has received several external proposals, including Letters of Intent and invitations to invest in various projects, as part of its ongoing strategic review. Following the discontinuation of the Phase III DIAGNODE-3 trial, the company is implementing cost-saving measures and evaluating strategic alternatives under the leadership of founder and CEO Anders Essen-Möller. Read the article here
|
26 maj 2026 Sweden
Umeå Biotech Incubator highlights Diamyd Medical’s GMP approval for its Umeå facility, noting its strategic importance for life science, regional preparedness and future pharmaceutical manufacturing. In the interview, Sofia Mayans, Head of Manufacturing Site Umeå, describes the approval as a major strength for the region. Read the full article here
|
21 maj 2026 Sweden
In an interview with BioStock, Sofia Mayans, Head of Manufacturing, comments on the GMP certification from the Swedish Medical Products Agency. The certification marks an important milestone for Diamyd Medical’s recombinant protein platform and strengthens the company’s position for future manufacturing, partnerships, and expansion opportunities. Read the article here
|